The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback